|
Phyisician Led CIMAvax-EGF lung biomarkers |
11/03/2021 |
CIM |
|
CIGB2020- ARI elderly contacts |
11/03/2021 |
CIGB |
|
Expanded Clinical Use of Nasalferon in COVID-19 |
10/11/2021 |
CIGB |
|
CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized. |
10/11/2014 |
CIGB |
|
Oncoxin-Viusid/Stomach and gastric esophagus union cancer / Adults / Phase II |
10/05/2018 |
CATALYSIS |
|
Cuban uterine manipulator, new device for the hysterectomy totally laparoscopic. |
10/02/2017 |
CNCMA |
|
CIGB-Mambisa/Abdala in convalescents |
09/07/2021 |
CIGB |
|
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory |
09/07/2018 |
CIM |
|
Glizigen® and Oncoxin®-Viusid® in cervical intraepithelial lesions of adult women. Phase II |
09/05/2018 |
CATALYSIS |
|
Itolizumab for Moderate-to-Severe Psoriasis-phase 3 |
08/10/2015 |
CIM |
|
VSSP in metastasic renal cell carcinoma |
08/08/2018 |
CIM |
|
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer |
08/07/2015 |
CIM |
|
Safety evaluation of Bacillus coagulans AO1167 for its use as a probiotic in humans |
07/08/2023 |
HHA |
|
Safety evaluation of Bacillus clausii AO1125 for its use as a probiotic in humans |
07/08/2023 |
HHA |
|
AMIGOS-2 study |
07/08/2018 |
CIGB |
|
CERVICONC-II-300 study |
07/08/2018 |
CIGB |
|
Quality of Life and safety of the nutritional supplement Deprexil® or Placebo in combination with cognitive stimulation treatment in patients with Mild Cognitive Impairment and Mild Alzheimer's Dementia. |
07/03/2024 |
CATALYSIS |
|
14F7 in chronic B-cell lymphoproliferative syndrome |
07/03/2018 |
CIM |
|
Nasal recombinant human interferon alfa-2b in ARI |
06/12/2022 |
CIGB |
|
Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 . |
06/11/2014 |
FINLAY |
